arrow
F

Floor Heubel-Moenen

Maastricht University
H指数:10
被引数:465

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Heavy Menstrual Bleeding in Women with a Bleeding Disorder of Unknown Cause: A common symptom impacting daily life functioning

原因不明的出血性疾病女性中月经量过多的研究:一种影响日常功能生活的常见症状

2026-09-080
OAAI
Psychometric properties and outcomes of the PROMIS® Sexual Function and Satisfaction measures in individuals with congenital bleeding disorders

PROMIS®性功能与满意度量表的测量属性和结果:先天性出血障碍患者研究

2026-09-020
OAAI
Assessing the real-world value of hemophilia care: how suitable are patient-centered outcomes for hospital-level comparisons?

评估血友病护理的真实世界价值:以患者为中心的结局是否适用于医院层面的比较?

2026-08-040
OAAI
A multicenter prospective observational cohort study to improve diagnostic yield and clinical management of persons with a Bleeding Disorder of Unknown Cause (BDUC-iN study protocol)

多中心前瞻性观察队列研究以提高原因不明出血性疾病患者的诊断效益和临床管理(BDUC-iN研究方案)

2026-08-010
PRE
Higher-Dosed Clotting Factor Prophylaxis Fails to Reduce Postpartum Hemorrhage in Women With von Willebrand Disease: Findings from the Observational PRegnancy and Inherited bleeding DisordErS study (PRIDES)

高剂量凝血因子预防无法降低冯·维勒布兰德病妇女的产后出血:观察性妊娠与遗传性出血障碍研究(PRIDES)的结果

2026-01-070
OAAI
Pharmacokinetic-guided dose reduction of emicizumab in congenital hemophilia A: Interim Analysis of the DosEmi Study

先天性血友病A中基于药代动力学的依米珠单抗剂量调整:DosEmi研究的期中分析

2025-11-070
OAAI
Bleeding disorder of unknown cause: an illustrated review on current practice, knowledge gaps, and future perspectives
2024-11-010
OAAI
Primary postpartum hemorrhage in women with von Willebrand disease and carriers of hemophilia: a retrospective analysis
2024-07-010
OAAI
Standardization of definition and management for bleeding disorder of unknown cause: communication from the SSC of the ISTH

不明原因出血性疾病的定义和管理的标准化: 来自ISTH SSC的交流

2024-07-0110
PRE
Predictive performance of pharmacokinetic-guided prophylactic dosing of factor concentrates in hemophilia A and B

药代动力学指导的血友病A和B因子浓缩物预防性给药的预测性能

2024-03-010
OAAI
Tachyphylaxis and reproducibility of desmopressin response in perioperative persons with nonsevere hemophilia A: implications for clinical practice
2024-03-011
OAAI
Peri-operative desmopressin combined with pharmacokinetic-guided factor VIII concentrate in non-severe haemophilia A patients

非重症a型血友病患者围手术期去氨加压素联合药代动力学指导的VIII因子浓缩物

2024-02-111
OA